Investigational Site Number 840208 — Chattanooga, Tennessee

Investigational Site Number 840208 is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number 840208 has participated in 2 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus, Squamous Cell Lung Cancer.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840208?

Investigational Site Number 840208 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840208 conducted?

Investigational Site Number 840208 has 2 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Squamous Cell Lung Cancer.

Is Investigational Site Number 840208 accredited by Crixeo Clinical Trials?

Investigational Site Number 840208 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840208?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.